Effects of metaraminol on the resistance and capacitance vessels in humans.
A. Baraka,S. Haroun,M. Baroody,M. Nawfal,A. Sibaii
DOI: https://doi.org/10.1213/00000539-198904000-00026
1989-04-01
Abstract:During cardiopulmonary bypass (CPB), we have previously shown in patients undergoing open heart surgery that injection of ephedrine 30 mg into the venous reservoir of the Bentley oxygenator increased the mean perfusion pressure (MAP) by about 30%, but decreased rather than increased the reservoir volume (RV) by about 30%, suggesting a moderate increase of the peripheral resistance associated with venodilation (1). The present report describes the peripheral vascular effects of metaraminol during CPB in 10 patients undergoing aortic and/or mitral valve replacement. Anesthesia was induced with diazepam 0.1 mgkg, a mixture of alcuronium 0.25 mg/kg and pancuronium 0.1 mg/kg, and fentanyl 20 &kg. After orotracheal intubation, controlled ventilation was performed using 100% 0, and anesthesia was maintained with incremental doses of morphine amounting to 0.5 mg/kg. The pump oxygenator was primed with 1.5 liter of lactated ringers solution. The patients were perfused with a constant pump flow 2.3 L/m2/min. After 10-20 minutes of CPB, a steady state of perfusion was reached. Metaraminol2 mg was then injected into the venous line of the Bentley oxygenator and its effect on the MAP and RV monitored. Changes in MAP and RV were considered to reflect changes of the peripheral vascular resistance and venous capacitance respectively. The injection of metaraminol2 mg was rapidly followed by a significant increase in the MAP to 125.5 * 39.5 mmHg from 64.5 5 13.2 mmHg, associated with an increase of the RV to 2950 * 1066 ml from 2690 * 1097 ml. The results of the present report shows that metaramino1 produces a marked increase of MAP associated with a moderate increase of RV. In contrast, ephedrine has been previously shown to produce in man a moderate increase of MAP associated with a decrease of RV (1). Metaraminol has some direct effect on vascular smooth muscle, but its primary effect is due to release of endogenous norepinephrine, which exerts p-adrenergic effects on the heart and a-adrenergic action on the blood vessels (2,3). Thus, metaraminol acts on the peripheral vessels, similar to norepinephrine, as a selective a-adrenergic agonists which can constrict both the resistance and capacitance vessels, while ephedrine acts as a mixed aand padrenergic agonist (2,3) which constricts the resistance vessels but dilates the capacitance vessels (1). Anis Baraka, MD Sania Haroun, MD Maurice Baroody, MD Maud Nawfal, MD Abla Sibaii, MS Department of Anesthesiology and Department of Epidemiology G. Biostatistics American University of Beirut Beiru t-Labanon